RA patients maintaining DAS28-CRP ( Disease Activity Score of 28 joints with C-reactive protein ) scores < 2.6 for 6 months with IFX were randomized either to receive addition of bucillamine ( BUC ) to MTX ( BUC + MTX group ; n = 24 ) or not ( MTX group ; n = 31 ) upon discontinuing IFX .